Upstream Bio, Inc. UPB

NASDAQ Price as of Nov 10, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jun 30, 2026

$3.37
$2.68
$46.12
Market cap
$184.58M
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
-17.5%
EPS growth YoY
1.4%
ROIC
-53.2%
Piotroski F-score
3

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) -17.5% 82.7%-100.2 pts 83.7%-101.2 pts
EPS growth YoY (qtr) 1.4% -47.1%+48.4 pts 88.6%-87.3 pts
Revenue growth (TTM) 16.0% 44.7%-28.7 pts ——
EPS growth (TTM) -166.4% -105.7%-60.8 pts ——
P/E (GAAP, TTM) — —— ——
P/E (operating) — —— ——
P/E (excl. gains) — —— ——
P/B 0.83 1.10-0.26 ——
ROIC -53.2% -53.2%0.0 pts -42.7%-10.5 pts
Net margin -5,026.0% -5,026.0%0.0 pts -2,650.0%-2,376.0 pts
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) -2.89 -2.90+0.3% 4.35-166.4%
Price $5.26 $6.92-24.0% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Jun 30, 2026 $773.00K -25.2% -17.5% -0.73 2.7% 1.4% -5,136.1%
Mar 31, 2026 $1.03M 54.8% 82.7% -0.75 3.8% -47.1% -3,925.6%
Dec 31, 2025 * $668.00K -2.2% 9.0% -0.78 -23.8% -106.2% -6,356.1%
Sep 30, 2025 $683.00K -27.1% 12.5% -0.63 14.9% 90.9% -4,941.1%
Jun 30, 2025 $937.00K 65.5% 83.7% -0.74 -45.1% 88.6% -4,265.3%
Mar 31, 2025 $566.00K -7.7% -11.6% -0.51 -104.1% 89.1% -4,818.0%
Dec 31, 2024 * $613.00K 1.0% — 12.56 280.5% — -3,465.3%
Sep 30, 2024 $607.00K 19.0% -2.3% -6.96 -7.1% -229.9% -2,634.6%
Jun 30, 2024 $510.00K -20.3% — -6.50 -38.9% — -2,878.0%
Mar 31, 2024 $640.00K — — -4.68 — — -1,702.2%
Dec 31, 2023 * — — — — — — —
Sep 30, 2023 $621.00K — — -2.11 — — -499.5%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 10, 2026 Date of the latest closing price used.
Price $3.37 Latest closing price.
Market cap $184.58M Price × shares outstanding.
Enterprise value $83.00M Market cap + debt − cash: the price of the whole business.
Shares 54.77M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -77.7% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -85.8% TTM EPS ÷ price.
P/B 0.54 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 64.67 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 58.45 Market cap ÷ revenue of the last four quarters.
P/FCF — Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA — Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales 29.08 Enterprise value ÷ revenue.
Book value / share 6.20 Shareholders' equity ÷ shares.
FCF yield -72.3% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS -2.31 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income — Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Jun 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $773.00K Revenue of the latest reported quarter.
Net income (qtr) -$39.70M Net income of the latest reported quarter.
EPS (qtr) -0.73 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) -17.5% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) -25.2% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) 1.4% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 2.7% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) 0.7% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 2.2% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -5,481.0% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -5,136.1% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $3.16M Revenue of the last four quarters.
Net income (TTM) -$156.50M Net income of the last four quarters.
EPS (TTM) -2.89 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 16.0% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) -166.4% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) -49.8% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio — Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date — Most recent ex-dividend date.
Buyback yield 0.0% Share repurchases ÷ market cap.
Shareholder yield 0.0% Dividend yield + buyback yield.
Profitability
Gross margin — Gross profit ÷ revenue (latest fiscal year).
EBITDA margin -5,612.2% EBITDA ÷ revenue.
Operating margin -5,618.8% Operating income ÷ revenue.
Net margin -5,026.0% Net income ÷ revenue.
FCF margin -4,675.5% Free cash flow ÷ revenue.
ROE -42.2% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -40.5% Return on assets: net income ÷ total assets.
ROIC -53.2% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 20.4% Latest fiscal year revenue vs the year before.
Net income growth (annual) -128.4% Latest fiscal year net income vs the year before.
EPS growth (annual) 52.3% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) — Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 26.15 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 26.15 (Current assets − inventory) ÷ current liabilities.
Cash ratio 7.55 Cash ÷ current liabilities.
Debt / equity 0.00 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.00 Total debt ÷ total assets.
Debt / EBITDA — Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA — (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage — Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -2.9% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 362.0% Share-based compensation ÷ revenue.
R&D % revenue 4,793.5% Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.01 Revenue ÷ total assets.
Days sales outstanding 85 Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables — Average days to pay suppliers.
Trading & momentum
52-week high $46.12 Highest price in the last 52 weeks.
52-week low $2.68 Lowest price in the last 52 weeks.
From 52-week high -92.7% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 25.7% How far above the 52-week low the price is.
Avg volume (30d) 951.25K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $3.02M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 3 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 6.25 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $2.85M Revenue of the latest fiscal year.
Net income -$143.44M Net income of the latest fiscal year.
Diluted EPS -2.66 Diluted earnings per share of the latest fiscal year.
EBITDA -$160.17M Operating income + depreciation & amortization.
Free cash flow -$133.44M Operating cash flow − capital spending.
Total debt $0 Long-term plus current debt.
Cash $101.58M Cash and equivalents.
Equity $339.77M Shareholders' equity.
Total assets $353.77M Total assets.